🌟 Flashback to May! Flor, a PhD student and Science Communications Ambassador, attended the ‘Cancer and the Host: Tumour Immunology’ Cancer Research UK (CRUK) conference at the Francis Crick Institute in London: https://ow.ly/3W0g50SfG2k Here are her top 3 reasons why attending conferences is essential for PhD students: 1️⃣ Stay updated with cutting-edge research 2️⃣ Expand your professional network 3️⃣ Receive valuable feedback on your work Watch Flor's Day In The Life video to hear her full experience and insights ⬇️
Manchester Cancer Research Centre’s Post
More Relevant Posts
-
Scientist and advocate. VP, Global Engagement and Research Partnerships at LUNGevity Foundation. Team CANCAN @Cancer Grand Challenges. Views = mine.
I hope you’ll join us for my conversation with Drs. Christine M. Lovly, MD, PhD and Smruthy Sivakumar about their tour de force analysis of 3600 #SCLC samples and what it means for patients with #lungcancer. #LCSM
Researchers may have found the keys to unlocking new treatments for small cell lung cancer (SCLC). Join Dr. Amy Moore as she meets with co-authors of this groundbreaking study -- Dr. Christine Lovly, a lung cancer researcher and physician at Vanderbilt University, and Dr. Smruthy Sivakumar, Sr. Scientist in the Computational Biology Discovery Program at Foundation Medicine -- to discuss their work identifying new subtypes of SCLC and what these discoveries mean for patients. RSVP and join here: https://fb.me/e/2QIjUkNUD
-
-
Check out the Fall 2023 issue of the Ludwig Link. Cancer research aficionados are in for a treat: this issue is packed with more news of scientific discoveries from Ludwig labs than any issue has delivered before. It also features a Q&A with Ludwig University of Oxford’s Richard White, who spoke with us about his life and equally interesting scientific discoveries modeling cancer in zebrafish. In our “Ask a scientist” section, Ludwig researchers weigh in on what they think we can do, as individuals and as a community, to help build public support for scientific research. https://bit.ly/40Z70kO
-
-
Important progress in the field
Research Update: From 2017 to 2020, the Foundation’s Andrew J. Lockhart Memorial Prize was awarded to five researchers who have advanced the field of focused ultrasound and cancer research. We recently checked in with the Lockhart Prize recipients to learn about the progress of their research and their future plans. Read about the recipients: https://lnkd.in/eCaUMHyn
-
-
🇨🇦 Owkin's team of experts is participating in the International Bladder Cancer Network conference (IBCN) in Montreal. Today, starting from 03:40pm EDT, don't miss our poster session presented by Simon Grouard, our Research Scientist, and Nadia Jeremiah, our Principal Scientist – Biomedical Discovery. They will discuss the groundbreaking application of multimodal deep learning models to predict treatment outcomes in muscle-invasive bladder cancer. Learn more at https://www.ibcnweb.com/ #bladdercancer #multimodal #deeplearning
-
-
Your guide to cancer research in Germany 🗺️ 👉 https://sohub.io/c6sg Cancer is one of the most challenging diseases to research: every cancer is different, as is every patient. The Research in Germany website for international researchers dedicates an entire page to the topic of #CancerResearch. Find a comprehensive overview 👀 over the German cancer research landscape, e. g.: 🏨 the most important players in the field 👩🏼🎓👨🏾🎓 master, PhD and postdoc programmes 💸 funding options 🤝 contacts If you are planning to do cancer research in Germany – this is your guide! 💡
-
-
Listen to a captivating conversation between Dr. Emil Lou, Associate Professor of Medicine at Masonic Cancer Center, University of Minnesota, and Dr. Chadi Nabhan, Chairman of Caris Precision Oncology Alliance™, about the intricate connections between pathogens and cancer. Tune in, gain valuable insights into the current landscape, and discover what the future holds for this dynamic intersection of science and medicine. https://ow.ly/OPqG50QtJvE
-
Beautiful explanation from Arutha Kulasinghe, discussing the combined strength of multiplex IF from Akoya Biosciences, Inc. and Navinci Diagnostics PD1/PD-L1 proximity ligation assay!! Why multiplex? How can I be sure there is signalling? Where? What can this tell us about response/non-response? Could it be predictive? This assay ticks a lot of boxes ✅
Throwback to this year's AACR ☀ As summer begins and conference season pauses, we are looking back on some highlights from earlier this year. We are excited to share a series of video presentations of posters our collaborators showcased during #AACR24 First up: in partnership with Akoya Biosciences, Inc. and Navinci, Dr Arutha Kulasinghe’s group at The University of Queensland integrated PD1/PD-L1 isPLA with the PhenoCode Signature Immune Panel to study protein-protein interactions in the broader context of the TME. See Arutha's presentation below, and follow the link to read more and view the poster: https://lnkd.in/eXMHnnvu American Association for Cancer Research
-
🔬 I recently had the opportunity to present at the 3rd German Cancer Research Congress held at our institution, the German Cancer Research Center (DKFZ). My presentation titled "Robust differentiation of irradiated mouse lungs from age-matched controls using pre-clinical mouse CT data with quantitative radiomics." 🌟 The highlight of our research involves developing a CT radiomics-based signature that distinguishes post-irradiation lung changes with high accuracy, which could be crucial for improving normal tissue complication probability models. #CancerResearch #DKFZ #Radiomics #Radiotherapy #PrecisionMedicine #PrecisionRadiotherapy #MachineLearning #ScientificCongress
-
-
We are broadening our ipsc-immune cell platform, introducing the scalable and continuous production of iPSC-NK cells and CAR-iPSC-Macrophages. @all youngster interested in translational #cancer research, come and join us. We will provide small snapshots on our work and the possibilities using #ipsc technology. link below #science #immunotherapy #patients #medicine #cells #nkcells #therapy
Little reminder - and the register deadline has been extended! All young cancer scientists are cordially invited to the second annual Young #Cancer #Scientist Symposium on Friday, November 10 at Hannover Medical School (MHH). The symposium will include poster presentations, a lecture series, and a career panel. Exchange ideas with other young cancer researchers and expand your network. You can look forward to a career panel with Prof. Nico Lachmann (MHH) & Dr. PD Ramona Ramona Schulz-Heddergott (UMG). CCC-N Younger Cancer Scientist Symposium Date: Friday, November 10, 2023 Time: 10:00 a.m. - 7:00 p.m. Location: Hannover Medical School, Carl-Neuberg-Strasse 1, 30625 Hannover, Lecture Hall C, Building J2. You can register now at https://lnkd.in/eunMDvqd. The register deadline has been extended: The deadline is now 10 October The meeting is organized by Prof. Günter Schneider (UMG) and Prof. Michael Heuser (MHH) of the CCC-N Translational Research Team.
-
Attending #AACR24? Pick up a copy of the AACR Journals Collection on Tumor Evolution at the Publications Booth (4043) during the American Association for Cancer Research Annual Meeting 2024. Explore the new and exciting avenues in the development of novel molecular diagnostic tools, patient stratification, selection of personalized treatment regimens, and strategies for overcoming resistance. https://bit.ly/3VU81tT American Association for Cancer Research
-
